ORIGINAL RESEARCH
Accepted on 06 May 2025
Metabolite Perturbations in Type 1 Diabetes Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease
doi 10.3389/fendo.2025.1500242
- Frontiers in Endocrinology
- Clinical Diabetes
- Research Topics
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Pathogenesis, Prevention and Treatment
7,174
Total downloads
23k
Total views and downloads
Articles
CASE REPORT
Accepted on 25 Apr 2025
Case report: Amelioration of severe metabolic dysfunction-associated steatohepatitis switching from conventional GLP-1RAs to tirzepatide
doi 10.3389/fendo.2025.1501984
- 171 views
ORIGINAL RESEARCH
Published on 17 Feb 2025
Impact of segmental body composition on metabolic dysfunction-associated fatty liver disease in Chinese children
doi 10.3389/fendo.2025.1505050
- 790 views
ORIGINAL RESEARCH
Published on 14 Jan 2025
The association between working hours and working type with non-alcoholic fatty liver disease: results from the NHANES 1999-2014
doi 10.3389/fendo.2024.1499735
- 1,160 views
ORIGINAL RESEARCH
Published on 13 Jan 2025
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
doi 10.3389/fendo.2024.1506953
- 704 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Dec 2024
Associations of serum folate and vitamin B12 levels with all-cause mortality among patients with metabolic dysfunction associated steatotic liver disease: a prospective cohort study
doi 10.3389/fendo.2024.1426103
- 1,649 views
ORIGINAL RESEARCH
Published on 21 Nov 2024
Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe
doi 10.3389/fmed.2024.1383112
- 1,190 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Sep 2024
Predicting cardiometabolic disease in medical students using FibroScan and 30-year Framingham risk scores
doi 10.3389/fmed.2024.1431935
- 2,691 views
ORIGINAL RESEARCH
Published on 25 Sep 2024
Identifying metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus using clinic-based prediction tools
doi 10.3389/fmed.2024.1425145
- 973 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Sep 2024
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study
doi 10.3389/fendo.2024.1451383
- 1,010 views
- 10 citations
REVIEW
Published on 23 May 2024
Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin
doi 10.3389/fendo.2024.1411706
- 2,554 views
- 4 citations
ORIGINAL RESEARCH
Published on 14 May 2024
Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017–2018
doi 10.3389/fendo.2024.1405828
- 3,993 views
- 9 citations
